BELLUS Health Inc.
BLU was delisted on the 28th of June, 2023.
89 hedge funds and large institutions have $727M invested in BELLUS Health Inc. in 2021 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 8 closing their positions.
425% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 8
200% more funds holding in top 10
Funds holding in top 10: 2 → 6 (+4)
136% more capital invested
Capital invested by funds: $307M → $727M (+$419M)
59% more funds holding
Funds holding: 56 → 89 (+33)
5% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 19
26% less call options, than puts
Call options by funds: $11.6M | Put options by funds: $15.6M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$67.9M |
| 2 |
PA
Perceptive Advisors
New York
|
+$50.7M |
| 3 |
AG
Artal Group
Luxembourg
|
+$21.6M |
| 4 |
CC
Commodore Capital
New York
|
+$20.7M |
| 5 |
DM
Deerfield Management
New York
|
+$16.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$9.84M |
| 2 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$8.08M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$7.74M |
| 4 |
O
OrbiMed
New York
|
-$6.64M |
| 5 |
IC
Ikarian Capital
Dallas,
Texas
|
-$4.61M |
BLU Hedge Fund Activity: Q4 2021 in Review
89 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in BELLUS Health Inc. (BLU) for Q4 2021, worth a combined $727M — up 136% from $307M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new BLU positions and 8 closed out — a net gain of 34 holders — while 20 added to existing stakes and 19 trimmed.
The largest buyer was RA Capital Management, opening a new position worth an estimated $67.9M. The largest seller was Acuta Capital Partners, cutting an estimated $9.84M.
- 89 institutional investors held BELLUS Health Inc. (BLU) as of Q4 2021, up from 56 in Q3 2021.
- Funds reported $727M of BELLUS Health Inc. stock for Q4 2021, up 136% quarter-over-quarter.
- 42 funds opened new BELLUS Health Inc. positions in Q4 2021 and 8 closed out, a net change of +34 holders.
- The largest BELLUS Health Inc. buyer in Q4 2021 was RA Capital Management, an estimated $67.9M added.
- The largest BELLUS Health Inc. seller in Q4 2021 was Acuta Capital Partners, an estimated $9.84M sold.
Based on aggregated 13F filings for Q4 2021.